164 related articles for article (PubMed ID: 7489565)
21. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells.
Huang S; Singh RK; Xie K; Gutman M; Berry KK; Bucana CD; Fidler IJ; Bar-Eli M
Cancer Immunol Immunother; 1994 Oct; 39(4):231-8. PubMed ID: 7954525
[TBL] [Abstract][Full Text] [Related]
22. Induction of acquired immunity in rats that have eliminated intracranial gliosarcoma cells by the expression of herpes simplex virus-thymidine kinase gene and ganciclovir administration.
Iwadate Y; Namba H; Tagawa M; Takenaga K; Sueyoshi K; Sakiyama S
Oncology; 1997; 54(4):329-34. PubMed ID: 9216859
[TBL] [Abstract][Full Text] [Related]
23. 7-Hydroxystaurosporine-induced apoptosis in 9L glioma cells provides an effective antigen source for dendritic cells and yields a potent vaccine strategy in an intracranial glioma model.
Witham TF; Erff ML; Okada H; Chambers WH; Pollack IF
Neurosurgery; 2002 Jun; 50(6):1327-34; discussion 1334-5. PubMed ID: 12015852
[TBL] [Abstract][Full Text] [Related]
24. Time course analysis and modulating effects of established brain tumor on active-specific immunotherapy.
Liu Y; Ng K; Lillehei KO
Neurosurg Focus; 2000 Dec; 9(6):e3. PubMed ID: 16817686
[TBL] [Abstract][Full Text] [Related]
25. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat.
Jean WC; Spellman SR; Wallenfriedman MA; Flores CT; Kurtz BP; Hall WA; Low WC
J Neurooncol; 2004 Jan; 66(1-2):39-49. PubMed ID: 15015768
[TBL] [Abstract][Full Text] [Related]
26. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
[TBL] [Abstract][Full Text] [Related]
27. NKR-P1+ cells localize selectively in Rat 9L gliosarcomas but have reduced cytolytic function.
Chambers WH; Bozik ME; Brissette-Storkus SC; Basse P; Redgate E; Watkins S; Boggs SS
Cancer Res; 1996 Aug; 56(15):3516-25. PubMed ID: 8758920
[TBL] [Abstract][Full Text] [Related]
28. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the 9L gliosarcoma implanted in the Fischer rat: an orthotopic model for a grade IV brain tumor.
Bouchet A; Bidart M; Miladi I; Le Clec'h C; Serduc R; Coutton C; Regnard P; Khalil E; Dufort S; Lemasson B; Laissue J; Pelletier L; Le Duc G
Tumour Biol; 2014 Jul; 35(7):6221-33. PubMed ID: 24633919
[TBL] [Abstract][Full Text] [Related]
30. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression.
Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC
J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253
[TBL] [Abstract][Full Text] [Related]
31. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells.
Rollins BJ; Sunday ME
Mol Cell Biol; 1991 Jun; 11(6):3125-31. PubMed ID: 2038321
[TBL] [Abstract][Full Text] [Related]
32. Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.
Ginzkey C; Eicker SO; Marget M; Krause J; Brecht S; Westphal M; Hugo HH; Mehdorn HM; Steinmann J; Hamel W
Cancer Immunol Immunother; 2010 Apr; 59(4):541-51. PubMed ID: 19798500
[TBL] [Abstract][Full Text] [Related]
33. [Experimental study of dendritic cells transfected with cancer stem like cells RNA against 9L brain tumors].
Xiao ZY; Chen XJ; Yang Y; Xu RX
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Aug; 47(4):661-6. PubMed ID: 26284406
[TBL] [Abstract][Full Text] [Related]
34. Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma.
Cool V; Pirotte B; Gérard C; Dargent JL; Baudson N; Levivier M; Goldman S; Hildebrand J; Brotchi J; Velu T
Hum Gene Ther; 1996 Mar; 7(5):627-35. PubMed ID: 8845388
[TBL] [Abstract][Full Text] [Related]
35. Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.
Parsa AT; Chi JH; Hurley PT; Jeyapalan SA; Bruce JN
Neurosurgery; 2001 Sep; 49(3):681-8; discussion 688-9. PubMed ID: 11523680
[TBL] [Abstract][Full Text] [Related]
36. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte macrophage-colony stimulating factor gene transfer to induce a protective anti-tumoral immune response against the 9L rat gliosarcoma model.
Lefranc F; Cool V; Velu T; Brotchi J; De Witte O
Int J Oncol; 2002 May; 20(5):1077-85. PubMed ID: 11956607
[TBL] [Abstract][Full Text] [Related]
38. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats.
Ram Z; Walbridge S; Shawker T; Culver KW; Blaese RM; Oldfield EH
J Neurosurg; 1994 Aug; 81(2):256-60. PubMed ID: 8027810
[TBL] [Abstract][Full Text] [Related]
39. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
